Related Experiment Video
Updated: May 1, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
Comprehensive functional annotation of 18 missense mutations found in suspected hemochromatosis type 4 patients
Isabelle Callebaut1, Rozenn Joubrel2, Serge Pissard3
1IMPMC, Sorbonne Universités - UMR CNRS 7590, UPMC Univ Paris 06, Muséum d'Histoire Naturelle, IRD UMR 206, Paris, France.
Insights
This study clarifies genetic mutations in ferroportin 1 (SLC40A1) causing hemochromatosis type 4. It distinguishes loss-of-function and gain-of-function variants, improving diagnosis and patient management for iron overload disorders.
Area of Science:
- Genetics
- Molecular Biology
- Biochemistry
Background:
- Hemochromatosis type 4 is a rare autosomal dominant iron overload disorder.
- It stems from mutations in the ferroportin 1 gene (SLC40A1).
- Mutations cause either loss-of-function or gain-of-function, leading to distinct clinical subtypes (4A and 4B).
Purpose of the Study:
- To investigate the causality of SLC40A1 missense variants in hemochromatosis type 4.
- To differentiate between loss-of-function and gain-of-function mutations.
- To understand the structural and functional impact of these mutations on ferroportin.
Main Methods:
- Integrated analysis of genetic and phenotypic data from 44 patients.
- In silico structural and functional annotations.
- Biochemical assays to assess protein function and expression.
Main Results:
- Causality confirmed for 10 missense variants, clearly separating type 4A and 4B.
- Identified two subgroups of loss-of-function mutations: impaired cell-surface expression and altered iron egress.
- Discovered a new gain-of-function mutation and elucidated ferroportin degradation mechanisms.
- Eight variants showed no discernible effect, associated with milder phenotypes.
Conclusions:
- Combining in silico and biochemical methods is crucial for distinguishing pathogenic SLC40A1 mutations from benign variants.
- Accurate mutation identification has significant implications for patient diagnosis and management.
- The study refines the understanding of ferroportin function and its role in iron overload.
Abstract:
Hemochromatosis type 4 is a rare form of primary iron overload transmitted as an autosomal dominant trait caused by mutations in the gene encoding the iron transport protein ferroportin 1 (SLC40A1). SLC40A1 mutations fall into two functional categories (loss- versus gain-of-function) underlying two distinct clinical entities (hemochromatosis type 4A versus type 4B). However, the vast majority of SLC40A1 mutations are rare missense variations, with only a few showing strong evidence of causality. The present study reports the results of an integrated approach collecting genetic and phenotypic data from 44 suspected hemochromatosis type 4 patients, with comprehensive structural and functional annotations. Causality was demonstrated for 10 missense variants, showing a clear dichotomy between the two hemochromatosis type 4 subtypes. Two subgroups of loss-of-function mutations were distinguished: one impairing cell-surface expression and one altering only iron egress. Additionally, a new gain-of-function mutation was identified, and the degradation of ferroportin on hepcidin binding was shown to probably depend on the integrity of a large extracellular loop outside of the hepcidin-binding domain. Eight further missense variations, on the other hand, were shown to have no discernible effects at either protein or RNA level; these were found in apparently isolated patients and were associated with a less severe phenotype. The present findings illustrate the importance of combining in silico and biochemical approaches to fully distinguish pathogenic SLC40A1 mutations from benign variants. This has profound implications for patient management.
More Related Videos
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Related Concept Videos
Gene Families
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...